Targeted Blood-pressure Management and Acute Kidney Injury After Coronary Artery Bypass Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorPeking University First Hospital

About this trial

Acute renal injury (AKI) is a common complication after cardiac surgery and is associated with worse outcomes. It is now realized that intraoperative hypotension is an important risk factor for the development of AKI. In a recent randomized controlled trial of patients undergoing major noncardiac surgery, intraoperative individualized blood-pressure management reduced the incidence of postoperative organ dysfunction. The investigators hypothesize that, for patients undergoing off-pump CABG, targeted blood-pressure management during surgery may also reduce the incidence of postoperative AKI.

Eligibility criteria

Qualifiers

Age ≥ 50 years;

Scheduled to undergo off-pump CABG surgery.

Disqualifiers

Refuse to participate;

Untreated or uncontrolled severe hypertension (systolic blood pressure ≥180 mmHg or diastolic blood pressure ≥110 mmHg);

Chronic kidney disease with a glomerular filtration rate < 30 ml/min/1.73 m2 or end-stage renal disease requiring renal-replacement therapy;

Inability to communicate during the preoperative period because of coma, profound dementia, language barrier, or end-stage disease;

Trial design

Treatments tested in this trial

  • Targeted blood-pressure management
  • Routine blood-pressure management

Treatment groups

612 Participants
are divided into 2 treatment groups